Pediatric Sarcoma Patients: Candidates for Immunotherapy?

Results from a small study suggest that immunotherapy may improve overall (OS) and progression-free survival in younger patients with Ewing sarcoma and rhabdomyosarcoma who respond to standard therapy (Clin Cancer Res 2016 Jan 28. [Epub ahead of print], PMID: 26823601). The authors, including researchers from the National Institutes of Health (NIH) and the University of Texas MD Anderson Cancer Center, administered a multicomponent adjuvant immunotherapy regimen to 29 patients with various